Shape Biopharmaceuticals

Developer of nanoparticle based immunotherapeutics for chronic human diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 language shapebiopharma.com

Investor mix

1 investor on record.

Investor typeCountShare
Accelerator & incubator1100%
Coming soon